1. Home
  2. BBN vs EVO Comparison

BBN vs EVO Comparison

Compare BBN & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Taxable Municipal Bond Trust of Beneficial Interest

BBN

BlackRock Taxable Municipal Bond Trust of Beneficial Interest

HOLD

Current Price

$15.58

Market Cap

964.6M

Sector

Finance

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.86

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBN
EVO
Founded
1983
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
964.6M
934.1M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
BBN
EVO
Price
$15.58
$2.86
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$7.00
AVG Volume (30 Days)
172.7K
91.4K
Earning Date
01-01-0001
04-08-2026
Dividend Yield
6.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.38
$2.31
52 Week High
$17.45
$4.80

Technical Indicators

Market Signals
Indicator
BBN
EVO
Relative Strength Index (RSI) 30.70 46.32
Support Level N/A $2.63
Resistance Level $16.71 $3.78
Average True Range (ATR) 0.14 0.09
MACD -0.06 -0.04
Stochastic Oscillator 14.67 33.38

Price Performance

Historical Comparison
BBN
EVO

About BBN BlackRock Taxable Municipal Bond Trust of Beneficial Interest

BlackRock Taxable Municipal Bond Trust is a diversified, closed-end management investment company. Its investment objective is to seek high current income, with a secondary objective of capital appreciation. The Trust seeks to achieve its investment objectives by investing in a portfolio of taxable municipal securities, including Build America Bonds (BABs), issued by state and local governments to finance capital projects such as public schools, roads, transportation infrastructure, bridges, ports and public buildings.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: